Hot Business News Today CRISPR Therapeutics (CRSP) Q4 Earnings Miss, Revenues Up Y/Y by Zacks Equity Research • February 16, 2022 • 0 Comments CRISPR Therapeutics (CRSP) reports wider-than-expected Q4 loss. Nonetheless, revenues beat estimates. Read more...
